Lessee, Operating Lease, Liability, to be Paid of SUPERNUS PHARMACEUTICALS, INC. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary: SUPERNUS PHARMACEUTICALS, INC. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
SUPERNUS PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2024 was $39,997,000.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$39,997,000			31 Dec 2024	10-K	25 Feb 2025	2024	FY
Q4 2022	$50,757,000	-$6,504,000	-11%	31 Dec 2022	10-K	09 Mar 2023	2022	FY
Q4 2021	$57,261,000	+$15,650,000	+38%	31 Dec 2021	10-K	13 Apr 2022	2021	FY
Q4 2020	$41,611,000	-$2,237,000	-5.1%	31 Dec 2020	10-K	08 Mar 2021	2020	FY
Q1 2020	$44,566,000	+$2,196,000	+5.2%	31 Mar 2020	10-Q	15 May 2020	2020	Q1
Q4 2019	$43,848,000			31 Dec 2019	10-K	28 Feb 2020	2019	FY
Q3 2019	$41,066,000			30 Sep 2019	10-Q	08 Nov 2019	2019	Q3
Q2 2019	$41,879,000			30 Jun 2019	10-Q	09 Aug 2019	2019	Q2
Q1 2019	$42,370,000			31 Mar 2019	10-Q	10 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.